Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer.
N Engl J Med. 2023 Nov 16;389(20):1851-1861. doi: 10.1056/NEJMoa2309719. Epub 2023 Oct 21.
N Engl J Med. 2023.
PMID: 37870969
Clinical Trial.
EWSR1::POU2AF3(COLCA2) Sarcoma: An Aggressive, Polyphenotypic Sarcoma With a Head and Neck Predilection.
Koshyk O, Dehner CA, van den Hout MFCM, Bempt IV, Sciot R, Huang HY, Agaimy A, Din NU, Klubíčková N, Mosaieby E, Skálová A, Michalová K, Schöffski P, Oliveira AM, Halling KC, Gupta S, Gross JM, Nin JWM, Michal M, Folpe AL, Kosemehmetoglu K, Torres-Mora J, Michal M.
Koshyk O, et al. Among authors: nin jwm.
Mod Pathol. 2023 Dec;36(12):100337. doi: 10.1016/j.modpat.2023.100337. Epub 2023 Sep 22.
Mod Pathol. 2023.
PMID: 37742928
Item in Clipboard
Impaired social functioning in adolescent and young adult sarcoma survivors: Prevalence and risk factors.
Drabbe C, Coenraadts ES, van Houdt WJ, van de Sande MAJ, Bonenkamp JJ, de Haan JJ, Nin JWM, Verhoef C, van der Graaf WTA, Husson O.
Drabbe C, et al. Among authors: nin jwm.
Cancer. 2023 May 1;129(9):1419-1431. doi: 10.1002/cncr.34689. Epub 2023 Feb 14.
Cancer. 2023.
PMID: 36787112
Free article.
Item in Clipboard
Higher plasma high-mobility group box 1 levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12 year follow-up study.
Nin JW, Ferreira I, Schalkwijk CG, Jorsal A, Prins MH, Parving HH, Tarnow L, Rossing P, Stehouwer CD.
Nin JW, et al.
Diabetologia. 2012 Sep;55(9):2489-93. doi: 10.1007/s00125-012-2622-1. Epub 2012 Jul 1.
Diabetologia. 2012.
PMID: 22752054
Free PMC article.
Item in Clipboard
Serum high-mobility group box-1 levels are positively associated with micro- and macroalbuminuria but not with cardiovascular disease in type 1 diabetes: the EURODIAB Prospective Complications Study.
Nin JW, Ferreira I, Schalkwijk CG, Prins MH, Chaturvedi N, Fuller JH, Stehouwer CD; EURODIAB Prospective Complications Study Group.
Nin JW, et al.
Eur J Endocrinol. 2012 Feb;166(2):325-32. doi: 10.1530/EJE-11-0662. Epub 2011 Nov 29.
Eur J Endocrinol. 2012.
PMID: 22127490
Item in Clipboard
Higher plasma soluble Receptor for Advanced Glycation End Products (sRAGE) levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study.
Nin JW, Jorsal A, Ferreira I, Schalkwijk CG, Prins MH, Parving HH, Tarnow L, Rossing P, Stehouwer CD.
Nin JW, et al.
Diabetes. 2010 Aug;59(8):2027-32. doi: 10.2337/db09-1509. Epub 2010 Jun 3.
Diabetes. 2010.
PMID: 20522598
Free PMC article.
Item in Clipboard
Levels of soluble receptor for AGE are cross-sectionally associated with cardiovascular disease in type 1 diabetes, and this association is partially mediated by endothelial and renal dysfunction and by low-grade inflammation: the EURODIAB Prospective Complications Study.
Nin JW, Ferreira I, Schalkwijk CG, Prins MH, Chaturvedi N, Fuller JH, Stehouwer CD; EURODIAB Prospective Complications Study Group.
Nin JW, et al.
Diabetologia. 2009 Apr;52(4):705-14. doi: 10.1007/s00125-009-1263-5. Epub 2009 Jan 30.
Diabetologia. 2009.
PMID: 19183936
Free article.
Item in Clipboard
Cite
Cite